Navigation Links
John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
Date:9/10/2007

ALEXANDRIA, Va., Sept. 10 /PRNewswire-USNewswire/ -- The American Diabetes Association (ADA), the leading non-profit health organization dedicated to preventing and curing diabetes and to improving the lives of nearly 21 million children and adults currently living with the disease, announced today that John B. Buse, MD, PhD of Chapel Hill, NC, has been elected President, Medicine & Science.

As President, Medicine & Science, Dr. Buse is one of the principal officers of the ADA and will serve as the principal spokesperson and advocate of the Association on scientific and medical matters. He will also work closely with ADA volunteers and staff on activities and programs in support of ADA's mission during his tenure.

Dr. Buse has chaired several of ADA's Committees and Task Forces as well as served as the Associate Editor of ADA's journals, Clinical Diabetes and Diabetes Care. He not only has held many positions and prestigious roles with ADA, but Dr. Buse is also an active fund raiser in his community helping to fight for a cure.

As an endocrinologist, Dr. Buse also serves as Chief of the Endocrinology Division of the Department of Medicine at the University of North Carolina (UNC) School of Medicine in Chapel Hill. In addition, he is an active clinician with a UNC-based diabetes practice in Chapel Hill.

Dr. Buse's research efforts include serving as the Vice-Chair of National Institutes of Health's (NIH's) largest ever diabetes study called the ACCORD study. This clinical trial is aimed at determining optimal treatments for diabetes, blood pressure and cholesterol in type 2 diabetes. Dr. Buse also serves as a co-investigator in the NIH's HEALTHY study which seeks to demonstrate that changing the school environment can be a catalyst for diabetes prevention in middle school children.

Dr. Buse received his bachelor's degree in Biochemistry from Dartmouth College and his Medical and Doctoral degrees from Duke University. He completed his internship and residency in internal medicine and his fellowship in endocrinology at the University of Chicago.

Diabetes is a serious disease that affects the body's ability to produce or respond properly to insulin, a hormone that allows blood sugar to enter the cells of the body and be used for energy. Nearly 21 million children and adults in the U.S. have diabetes. It is the fifth deadliest disease in the U.S. and it has no cure.

The American Diabetes Association is the nation's premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association has offices in every region of the country, providing services to hundreds of communities. The Association's commitment to research is reflected through its scientific meetings; education and provider recognition programs; and its Research Foundation and Nationwide Research Program, which fund breakthrough studies looking into the cure, prevention, and treatment of diabetes and its complications. For more information, please visit diabetes.org or call 1-800-DIABETES (1-800-342-2383).


'/>"/>
SOURCE American Diabetes Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Significant role of genetics in drug abuse, Norwegian study
2. Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows
3. Alcohol Abuse, Addiction Hits 3 of 10 Americans
4. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
5. Six Towns in India Selected for Eco-City Project
6. Abstain from sex- the latest mantra of American teens
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. American scientists alter gene makeup of babies
9. FDA attacks American Red Cross for blood violations
10. Poll Finds Many Americans Misinformed About Cancer
11. Poll Finds Many Americans Misinformed About Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2017)... ... May 28, 2017 , ... Starting in May, patients at ... Heart Rate Variability (HRV) diagnostic test. , Nerve-Express, originally designed for the Navy in ... the state of a patient’s autonomic nervous system (ANS). The ANS controls all ...
(Date:5/28/2017)... ... May 28, 2017 , ... Florida ... to announce that Sheldon K. Cho, MD, has joined its Winter Haven practice. ... that concentrates on minimally invasive techniques to treat and manage many types of ...
(Date:5/27/2017)... ... , ... Hate visiting the dentist? You should go twice per year for checkups, but if ... at home. Here are some dental tips to help out: , 1. Brushing Teeth - ... work desk or a locker at school for a quick brushing after lunch. Use a ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar with the sound of ... from the Osteoarthritis Initiative shows that certain people who experience consistent joint popping, ... may give doctors the opportunity to treat patients before the problem becomes pronounced, potentially ...
(Date:5/26/2017)... Massachsetts (PRWEB) , ... May 26, 2017 , ... ... will gather at Boston CEO 2017 on May 30th and 31st at The ... networking forum for leading executives in the life sciences, offering exclusive access to ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... -- Enterin Inc., a privately-held CNS pharmaceutical company based in ... treat Parkinson,s disease (PD), has enrolled the first patient in ... controlled, multicenter study involving patients with PD and taking place ... a 9-to-12-month period. The first stage is open label and ... sites include Denver , Boca ...
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: